Takeda Pharmaceutical (Germany) Buy Hold or Sell Recommendation

TKD Stock  EUR 25.01  0.12  0.48%   
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Takeda Pharmaceutical is 'Cautious Hold'. Macroaxis provides Takeda Pharmaceutical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TKD positions.
  
Check out Takeda Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Takeda and provide practical buy, sell, or hold advice based on investors' constraints. Takeda Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Takeda Pharmaceutical Buy or Sell Advice

The Takeda recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Takeda Pharmaceutical. Macroaxis does not own or have any residual interests in Takeda Pharmaceutical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Takeda Pharmaceutical's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Takeda PharmaceuticalBuy Takeda Pharmaceutical
Cautious Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Takeda Pharmaceutical has a Mean Deviation of 0.862, Standard Deviation of 1.12 and Variance of 1.25
Our trade recommendation module complements current analysts and expert consensus on Takeda Pharmaceutical. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time. To make sure Takeda Pharmaceutical is not overpriced, please validate all Takeda Pharmaceutical fundamentals, including its shares owned by institutions, price to book, revenue, as well as the relationship between the price to earning and price to sales .

Takeda Pharmaceutical Trading Alerts and Improvement Suggestions

Takeda Pharmaceutical generated a negative expected return over the last 90 days
Takeda Pharmaceutical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations

Takeda Pharmaceutical Returns Distribution Density

The distribution of Takeda Pharmaceutical's historical returns is an attempt to chart the uncertainty of Takeda Pharmaceutical's future price movements. The chart of the probability distribution of Takeda Pharmaceutical daily returns describes the distribution of returns around its average expected value. We use Takeda Pharmaceutical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Takeda Pharmaceutical returns is essential to provide solid investment advice for Takeda Pharmaceutical.
Mean Return
-0.11
Value At Risk
-1.59
Potential Upside
1.85
Standard Deviation
1.12
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Takeda Pharmaceutical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Takeda Pharmaceutical Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Takeda Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Takeda Pharmaceutical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Takeda stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-0.12
β
Beta against Dow Jones0.01
σ
Overall volatility
1.10
Ir
Information ratio -0.13

Takeda Pharmaceutical Volatility Alert

Takeda Pharmaceutical exhibits very low volatility with skewness of 0.74 and kurtosis of 0.5. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Takeda Pharmaceutical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Takeda Pharmaceutical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Takeda Pharmaceutical Fundamentals Vs Peers

Comparing Takeda Pharmaceutical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Takeda Pharmaceutical's direct or indirect competition across all of the common fundamentals between Takeda Pharmaceutical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Takeda Pharmaceutical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Takeda Pharmaceutical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Takeda Pharmaceutical by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Takeda Pharmaceutical to competition
FundamentalsTakeda PharmaceuticalPeer Average
Return On Equity0.0477-0.31
Return On Asset0.0247-0.14
Profit Margin0.07 %(1.27) %
Operating Margin0.13 %(5.51) %
Current Valuation71.16 B16.62 B
Shares Outstanding1.56 B571.82 M
Shares Owned By Insiders1.20 %10.09 %
Shares Owned By Institutions41.30 %39.21 %
Price To Earning19.43 X28.72 X
Price To Book0.95 X9.51 X
Price To Sales0.01 X11.42 X
Revenue3.57 T9.43 B
Gross Profit2.44 T27.38 B
EBITDA1.05 T3.9 B
Net Income230.06 B570.98 M
Cash And Equivalents3.41 B2.7 B
Cash Per Share4.36 X5.01 X
Total Debt4.14 T5.32 B
Debt To Equity114.80 %48.70 %
Current Ratio1.22 X2.16 X
Book Value Per Share3,973 X1.93 K
Cash Flow From Operations1.12 T971.22 M
Earnings Per Share1.21 X3.12 X
Price To Earnings To Growth0.58 X4.89 X
Number Of Employees47.35 K18.84 K
Beta0.7-0.15
Market Capitalization44.8 B19.03 B
Total Asset13.18 T29.47 B
Annual Yield0.04 %
Five Year Return3.51 %
Net Asset13.18 T
Last Dividend Paid180.0

Takeda Pharmaceutical Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Takeda . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Takeda Pharmaceutical Buy or Sell Advice

When is the right time to buy or sell Takeda Pharmaceutical? Buying financial instruments such as Takeda Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Takeda Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Books Thematic Idea Now

Books
Books Theme
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Takeda Stock

Takeda Pharmaceutical financial ratios help investors to determine whether Takeda Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takeda with respect to the benefits of owning Takeda Pharmaceutical security.